MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+22.2%
5Y CAGR+230.9%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+22.2%/yr
Annual compound
5Y CAGR
+230.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
396.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$41.97M+38.4%
2024$30.32M+35.8%
2023$22.32M-3.0%
2022$23.01M+27.5%
2021$18.05M+16965.6%
2020$105755.00-